local_hospital

Stella-Gyn s.r.o.

Address
lock Available on a paid plan

Stella-Gyn s.r.o. - Women's Health Research Center

Stella-Gyn s.r.o. is a specialized clinical research center dedicated to advancing women's health through innovative therapeutic studies. The center demonstrates expertise in gynecological conditions, reproductive health, and hormone-related disorders, with a particular focus on improving quality of life for women across different life stages.

  • Contraceptive development and efficacy studies, including novel delivery systems and bone health impact assessment
  • Vasomotor symptoms management in breast cancer patients receiving adjuvant endocrine therapy
  • Endometriosis-related pain treatment and novel therapeutic approaches

The research portfolio reflects a comprehensive approach to women's reproductive health, encompassing both prevention of pregnancy through advanced contraceptive methods and treatment of complex conditions such as endometriosis. The center's participation in studies evaluating vasomotor symptoms in breast cancer survivors demonstrates commitment to addressing the broader spectrum of women's health needs, including supportive care for oncology patients experiencing treatment-related side effects.

Site Overview

assignment
7
connected trials
corporate_fare
4
sponsors
science
7
IMPs

Activity Indicator

Last 6 months

1
Trials started
-50% vs previous period.
2
Trials started 6–12 months ago
7
Total trials linked
Active
trending_downDeclining-50%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 6 therapeutic areas and 7 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
4
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
7
Outperforms 79% of sites
public
Therapeutic diversity
6areas
Outperforms 93% of sites
groups
Sponsor diversity
4sponsors
Outperforms 74% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Stella-Gyn s.r.o.

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.Chemo Research S.L.Phase IIINot RecruitingJul 2023Aug 2025

IMP list

lock Showing 1 of 7 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
DROSPIRENONE2Unknown2022-08-222022-08-22

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.